The Optimal Timing Of Primaquine To Prevent Malaria Transmission After Artemisinin-Combination Therapy
Clinical trial NCT01906788 · UNKNOWN
Trial details
- NCT number
- NCT01906788
- Sponsor
- Kilimanjaro Clinical Research Institute
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2013-10-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.